Related Experiment Video
Updated: Aug 11, 2026
11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Hepatitis E virus genotyping based on full-length genome and partial genomic regions
Lijie Zhai1, Xing Dai, Jihong Meng
1Department of Microbiology and Immunology, School of Medicine, Southeast University, 87# Dingjiaqiao Rd., Nanjing, Jiangsu 210009, China. zhailj@iastate.edu
Virus Research
|February 14, 2006
Summary
A novel genomic region in the RNA-dependent RNA polymerase domain was identified for accurate hepatitis E virus (HEV) genotyping. This region, spanning 4254-4560nt, shows high concordance with full-genome phylogenetic analysis, simplifying HEV strain classification.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Accurate hepatitis E virus (HEV) genotyping is crucial for understanding its epidemiology.
- Previous studies have explored partial genomic regions for HEV genotyping, but a consensus region remains undetermined.
- Systematic investigation using combined phylogenetic and statistical approaches is lacking.
Purpose of the Study:
- To identify a reliable and consistent genomic region for HEV genotyping.
- To compare the efficacy of 24 partial genomic regions against the complete genome for phylogenetic analysis.
- To validate a statistically determined region for HEV genotyping.
Main Methods:
- Statistical comparison of nucleotide identities and genetic distances for 24 partial genomic regions and 37 complete HEV genome sequences.
- One-way and two-way ANOVA were employed for statistical analysis.
- Phylogenetic analysis and RT-PCR amplification were used to validate the identified region.
Main Results:
- A single genomic region within the RNA-dependent RNA polymerase domain (4254-4560nt) showed no significant difference compared to the full-length genome (P>0.05).
- Phylogenetic analysis using this region identified the same four HEV genotypes as the complete genome.
- RT-PCR confirmed conserved flanking primer sites, and clinical samples were successfully genotyped using this region.
Conclusions:
- The identified genomic region (4254-4560nt) is a reliable marker for HEV genotyping.
- This region offers a statistically validated and phylogenetically consistent alternative to full-genome analysis.
- The findings facilitate standardized and efficient HEV genotyping in clinical and research settings.
